Radiation-induced angiogenic signaling pathway in endothelial cells obtained from normal and cancer tissue of human breast

Oncogene

Volumn 33, Issue 10, 2014, Pages 1229-1238

  Oh, E T ^a   Park, M T ^a   Song, M J ^a   Lee, H ^a   Cho, Y U ^a   Kim, S J ^a   Chu, Y C ^a   Choi, E K ^b   Park, H J ^a  

^a Inha University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

angiogenesis; cancer endothelial cells; ionizing radiation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOPOIETIN; ANGIOSTATIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CD31 ANTIGEN; CESIUM 137; COLLAGEN TYPE 18; ENDOGLIN; GELATINASE A; GELATINASE B; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PLASMINOGEN; PROTEIN KINASE B; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CAPILLARY TUBE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IONIZING RADIATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIATION RESPONSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ZYMOGRAPHY;

ANGIOSTATINS; BREAST NEOPLASMS; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; NEOVASCULARIZATION, PATHOLOGIC; PLASMINOGEN; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84895921269     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.70     Document Type: Article

References (61)

1. Barcellos-Hoff MH, Park C, Wright EG. Radiation and the microenvironmenttumorigenesis and therapy. Nat Rev Cancer 2005; 5: 867-875
2. Park HJ, Griffin RJ, Hui S, Levitt SH, Song CW. Radiation-induced vascular damage in tumors: Implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res 2012; 177: 311-327
3. Truman JP, Garci'a-Barros M, Kaag M, Hambardzumyan D, Stancevic B, Chan M et al. Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization During tumor radiosurgery. PLoS One 2010; 5: E12310
4. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003; 300: 1155-1159
5. Park MT, Oh ET, Song MJ, Kim WJ, Cho YU, Kim SJ et al. The radiosensitivity of endothelial cells isolated from human breast cancer and normal tissue in vitro. Microvasc Res 2012; 84: 140-148
6. Brown M, Bristow R, Glazer P, Hill R, McBride W, McKenna G et al. Comment on tumor response to radiotherapy regulated by endothelial cell apoptosis (II). Science 2003; 302: 1894
7. Gerweck LE, Vijayappa S, Kurimasa A, Ogawa K, Chen DJ. Tumor cell radiosensitivity is a major determinant of tumor response to radiation. Cancer Res 2006; 66: 8352-8355
8. Park MT, Oh ET, Song MJ, Lee H, Park HJ. Radio-sensitivities and angiogenic signaling pathways of irradiated normal endothelial cells derived from diverse human organs. J Radiat Res 2012; 53: 570-580
9. Fokas E, McKenna WG, Muschel RJ. The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies. Cancer Metastasis Rev 2012; 31: 823-842
10. Moeller BJ, Cao Y, Li CY, Dewhirst MW. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004; 5: 429-441
11. Skuli N, Monferran S, Delmas C, Favre G, Bonnet J, Toulas C et al. Alphavbeta3/ alphavbeta5 integrins-FAK-RhoB: A novel pathway for hypoxia regulation in glioblastoma. Cancer Res 2009; 69: 3308-3316
12. Bussink J, van Der Kogel AJ, Kaanders JH. Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer. Lancet Oncol 2008; 9: 288-296
13. Chan DA, Giaccia AJ. Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev 2007; 26: 333-339
14. Verhoeff JJ, Stalpers LJ, Claes A, Hovinga KE, Musters GD, Peter Vandertop W et al. Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma. Eur J Cancer 2009; 45: 3074-3080
15. Sofia Vala I, Martins LR, Imaizumi N, Nunes RJ, Rino J, Kuonen F et al. Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis. PLoS One 2010; 5: E11222
16. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 2003; 92: 827-839
17. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-174
18. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17: 463-516
19. Djonov V, Cresto N, Aebersold DM, Burri PH, Altermatt HJ, Hristic M et al. Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer. Int J Oncol 2002; 21: 25-30
20. Creemers EE, Cleutjens JP, Smits JF, Daemen MJ. Matrix metalloproteinase inhibition after myocardial infarction: A new approach to prevent heart failure?. Circ Res 2001; 89: 201-210
21. Ribatti D. Endogenous inhibitors of angiogenesis: A historical review. Leuk Res 2009; 33: 638-644
22. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-285
23. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-328
24. Nguyen V, Gaber MW, Sontag MR, Kiani MF. Late effects of ionizing radiation on the microvascular networks in normal tissue. Radiat Res 2000; 154: 531-536
25. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31
26. Hida K, Hida Y, Amin DN, Flint AF, Panigrahy D, Morton CC et al. Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res 2004; 64: 8249-8255
27. Konerding MA, Fait E, Gaumann A. 3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon. Br J Cancer 2001; 84: 1354-1362
28. Song CW, Levitt SH. Quantitative study of vascularity in Walker carcinoma 256. Cancer Res 1971; 4: 31-39
29. Lunt SJ, Chaudary N, Hill RP. The tumor microenvironment and metastatic disease. Clin Exp Metastasis 2009; 26: 19-34
30. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E et al. Genes expressed in human tumor endothelium. Science 2000; 289: 1197-1202
31. Hida K, Hida Y, Shindoh M. Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies. Cancer Sci 2008; 99: 459-466
32. Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 2002; 90: 1243-1250
33. Kim KH, Yang CS, Shin AR, Jeon SR, Park JK, Kim HJ et al. Mycobacterial heparinbinding hemagglutinin antigen activates inflammatory responses through PI3-K/ Akt, NF-kB, and MAPK pathways. Immune Netw 2011; 11: 123-133
34. Lin HY, Tang CH, Chen JH, Chuang JY, Huang SM, Tan TW et al. Peptidoglycan induces interleukin-6 expression through the TLR2 receptor, JNK, c-Jun, and AP-1 pathways in microglia. J Cell Physiol 2011; 226: 1573-1582
35. Bannach FG, Gutierrez-Fernandez A, Parmer RJ, Miles LA. Interleukin-6-induced plasminogen gene expression in murine hepatocytes is mediated by transcription factor CCAAT/enhancer binding protein beta (C/EBPbeta). J Thromb Haemost 2004; 2: 2205-2212
36. Park HJ, Lee SH, Chung H, Rhee YH, Lim BU, Ha SW et al. Influence of environmental pH on G2-phase arrest caused by ionizing radiation. Radiat Res 2003; 159: 86-93
37. Chen FH, Chiang CS, Wang CC, Fu SY, Tsai CS, Jung SM et al. Vasculatures in tumors growing from preirradiated tissues: Formed by vasculogenesis and resistant to radiation and antiangiogenic therapy. Int J Radiat Oncol Biol Phys 2011; 80: 1512-1521
38. Karar J, Maity A. Modulating the tumor microenvironment to increase radiation responsiveness. Cancer Biol Ther 2009; 8: 1994-2001
39. Milliat F, Franc'ois A, Isoir M, Deutsch E, Tamarat R, Tarlet G et al. Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: Implication in radiation-induced vascular damages. Am J Pathol 2006; 169: 1484-1495
40. Ahmad M, Khurana NR, Jaberi JE. Ionizing radiation Decreases capillary-like structure formation by endothelial cells in vitro. Microvasc Res 2007; 73: 14-19
41. Vincenti S, Brillante N, Lanza V, Bozzoni I, Presutti C, Chiani F et al. HUVEC respond to radiation by inducing the expression of pro-angiogenic microRNAs. Microvasc Res 2007; 73: 14-19
42. Haimovitz-Friedman A, Witte L, Chaudhuri A, McLoughlin M, Fuks Z. Induction of growth factor genes in endothelial cells by ionizing radiation. Radiat Oncol Invest 1995; 3: 1-8
43. Chou CH, Chen SU, Cheng JC. Radiation-induced interleukin-6 expression through MAPK/p38/NF-kappaB signaling pathway and the resultant antiapoptotic effect on endothelial cells through Mcl-1 expression with sIL6-Ralpha. Int J Radiat Oncol Biol Phys 2009; 75: 1553-1561
44. Gorski DH, Mauceri HJ, Salloum RM, Gately S, Hellman S, Beckett MA et al. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Res 1998; 58: 5686-5689
45. Ji WR, Castellino FJ, Chang Y, Deford ME, Gray H, Villarreal X et al. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. FASEB J 1998; 12: 1731-1738
46. Soff GA. Angiostatin and angiostatin-related proteins. Cancer Metastasis Rev 2000; 19: 97-107
47. Burwick NR, Wahl ML, Fang J, Zhong Z, Moser TL, Li B et al. An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface. J Biol Chem 2005; 280: 1740-1745
48. Wei J, Zhou S, Bachem MG, Debatin KM, Beltinger C. Infiltration of blood outgrowth endothelial cells into tumor spheroids: Role of matrix metalloproteinases and irradiation. Anticancer Res 2007; 27: 1415-1421
49. Badiga AV, Chetty C, Kesanakurti D, Are D, Guirati M, Klopfenstein JD et al. MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells. PLoS One 2011; 6: E20614
50. Vorotnikova E, Tries M, Retinoids BraunhutS. and TIMP1 prevent radiation-induced apoptosis of capillary endothelial cells. Radiat Res 2004; 161: 174-184
51. Zhao W, Goswami PC, Robbins ME. Radiation-induced up-regulation of Mmp2 involves increased mRNA stability, redox modulation, and MAPK activation. Radiat Res 2004; 161: 418-429
52. Adya R, Tan BK, Punn A, Chen J, Randeva HS. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: Novel insights into visfatin-induced angiogenesis. Cardiovasc Res 2008; 78: 356-365
53. Wu WT, Chen CN, Lin CI, Chen JH, Lee H. Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells. Endocrinology 2005; 146: 3387-3400
54. von Offenberg Sweeney N, Cummins PM, Birney YA, Cullen JP, Redmond EM, Cahill PA. Cyclic strain-mediated regulation of endothelial matrix metalloproteinase-2 expression and activity. Cardiovasc Res 2004; 63: 625-634
55. Shao Z, Bhattacharya K, Hsich E, Park L, Walters B, Germann U et al. c-Jun N-terminal kinases mediate reactivation of Akt and cardiomyocyte survival after hypoxic injury in vitro and in vivo. Circ Res 2006; 98: 111-118
56. Meeren AV, Bertho JM, Vandamme M, Gaugler MH. Ionizing radiation enhances IL-6 and IL-8 production by human endothelial cells. Mediators Inflamm 1997; 6: 185-193
57. Fee D, Grzybicki D, Dobbs M, Ihyer S, Clotfelter J, Macvilay S et al. Interleukin 6 promotes vasculogenesis of murine brain microvessel endothelial cells. Cytokine 2000; 12: 655-665
58. Nilsson MB, Langley RR, Fidler IJ. Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res 2005; 65: 10794-10800
59. Hatzi E, Murphy C, Zoephel A, Rasmussen H, Morbidelli L, Ahorn H et al. N-myc oncogene overexpression Down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth. Oncogene 2002; 21: 3552-3561
60. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140: 883-899
61. Pang X, Yi Z, Zhang X, Sung B, Qu W, Lain X et al. Acetyl-11-keto-b- boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Cancer Res 2009; 69: 5893-5900